An explorative study of non-invasive ultra-weak photon emission and the anti-oxidative influence of oral zinc sulphate in light-sensitive patients with erythropoietic protoporphyria

Skin Research and Technology

Volumn 18, Issue 4, 2012, Pages 405-412

  Petersen, Anita Birgit ^a   Philipsen, Peter Alshede ^a   Wulf, Hans Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Erythropoietic protoporphyria; Photomultiplier; Photon emission; Ultra weak; Zinc

Indexed keywords

BLOOD SAMPLES; ERYTHROPOIETIC PROTOPORPHYRIA; FERROCHELATASE; HAEMOGLOBINS; HEALTHY INDIVIDUALS; IN-VIVO; INHERITED DISORDERS; INVERSE CORRELATION; LIGHT EXPOSURE; OXIDATIVE PROCESS; PHOTON EMISSIONS; PROTOPORPHYRIN IX; REACTIVE OXYGEN SPECIES; SOLAR-SIMULATED LIGHT; ULTRA-WEAK; ZINC CONCENTRATION; ZINC SULPHATE;

BIOCHEMISTRY; BLOOD; PHOTOMULTIPLIERS; PHOTONS; PHOTOSENSITIVITY; PLASMAS; ZINC;

PATIENT TREATMENT;

FERRITIN; HEMOGLOBIN; IRON; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE; ZINKLET;

ARTICLE; BLOOD SAMPLING; BUTTOCK; CLINICAL ARTICLE; ERYTHROCYTE; ERYTHROPOIETIC PROTOPORPHYRIA; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; LIGHT EXPOSURE; PHOTON; PHOTOSENSITIVITY; SIMULATION; SKIN PIGMENTATION; SPRING; SUMMER; TRANSFERRIN BLOOD LEVEL; ULTRA WEAK PHOTON EMISSION; ULTRAVIOLET A RADIATION; ZINC BLOOD LEVEL;

ADMINISTRATION, ORAL; ANTIOXIDANTS; ASTRINGENTS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; PHOTOMETRY; PHOTONS; PHOTOSENSITIVITY DISORDERS; PILOT PROJECTS; PORPHYRIA, ERYTHROPOIETIC; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ZINC SULFATE;

EID: 84867535856     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2011.00586.x     Document Type: Article

References (26)

1. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994; 131: 751-766.
2. Dalton J, McAuliffe CA. Reaction between molecular oxygen and photo-excited protoporphyrin IX. Nature 1972; 235: 171.
3. Spikes JD. Photobiology of porphyrins. Prog Clin Biol Res 1984; 170: 19-39.
4. Sauermann G, Mei WP, Hoppe U, Stäb F. Ultraweak photon emission of human skin in vivo: influence of topically applied antioxidants on human skin. Methods Enzymol 1999; 300: 419-428.
5. Khabiri F, Hagens R, Smuda C et al. Non-invasive monitoring of oxidative skin stress by ultraweak photon emission (UPE)-measurement. I: mechanisms of UPE of biological materials. Skin Res Tech 2008; 14: 103-111.
6. Hagens R, Khabiri F, Schreiner V et al. Non-invasive monitoring of oxidative skin stress by ultraweak photon emission measurement. II: biological validation on ultraviolet A-stressed skin. Skin Res Tech 2008; 14: 112-120.
7. Ou-Yang H, Stamatas G, Saliou C, Kollias N. A chemiluminescence study of UVA-induced oxidative stress in human skin in vivo. J Invest Dermatol 2004; 122: 1020-1029.
8. Ou-Yang H, Stamatas G, Kollias N. Dermal contributions to UVA-induced oxidative stress in skin. Photodermatol Photoimmunol Photomed 2009; 25: 65-70.
9. Minder EI, Schneider-Yin X, Bachmann LM. A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) 2009; 55: 84-97.
10. Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 2007; 110: 4108-4110.
11. Milligan A, Graham-Brown RAC, Sarkany I, Baker H. Erythropoietic protoporphyria exacerbated by oral iron therapy. Br J Dermatol 1988; 119: 63-66.
12. Baker H. Erythropoietic protoporphyria provoked by iron therapy. Proc roy Soc Med 1971; 64: 10.
13. Crofton RW, Gvozdanovic D, Gvozdanovic S et al. Inorganic zinc and the intestinal absorption of ferrous iron. Am J Clin Nutr 1989; 50: 141-144.
14. Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L. Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 1991; 54: 152-156.
15. Solomons NW. Competitive interaction of iron and zinc in the diet: consequences for human nutrition. J Nutr 1986; 116: 927-935.
16. Petersen AB, Philipsen PA, Wulf HC. Zinc sulphate - a new concept of treatment of EPP. Br J Dermatol 2011; in press.
17. Bettger WJ, O′Dell BL. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 1981; 28: 1425-1438.
18. Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Rad Biol Med 2001; 31: 266-274.
19. Wulf HC. Method and apparatus for determining an individual′s ability to stand exposure to UV. US patent 1986; 14: 882, 598:1-32.
20. Rastogi A, Pospisil P. Ultra-weak photon emission as a non-invasive tool for monitoring of oxidative processes in the epidermal cells of human skin: comparative study on the dorsal and the palm side of the hand. Skin Res Tech 2010; 16: 365-370.
21. Jain A, Rieger I, Rohr M, Schrader A. Antioxidant efficacy on human skin in vivo investigated by UVA-induced chemiluminescence decay analysis via induced chemiluminescence of human skin. Skin Pharmacol Physiol 2010; 23: 266-272.
22. Diffey BL, Jansén CT, Urbach F, Wulf HC. The standard erythema dose: a new photobiological concept. Photodermatol Photoimmunol Photomed 1997; 13: 64-66.
23. Van Wijk EPA, Van Wijk R, Bosman S. Using ultra-weak photon emission to determine the effect of oligomeric proanthocyanidins on oxidative stress of human skin. J Photochem Photobiol B 2010; 98: 199-206.
24. Petersen AB, Gniadecki R, Vicanova J, Thorn T, Wulf HC. Hydrogen peroxide is responsible for UVA-induced DNA-damage measured by alkaline comet assay in HaCaT keratinocytes. J Photochem Photobiol B 2000; 59: 123-131.
25. Poh-Fitzpatrick MB. Human protoporphyria: reduced cutaneous photosensitivity and lower porphyrin levels during pregnancy. J Am Acad Dermatol 1997; 36: 40-43.
26. Zago MP, Verstraeten SV, Oteiza PI. Zinc in the prevention of Fe2+ -initiated lipid and protein oxidation. Biol Res 2000; 33: 143-150.